TUNABLE NANOPARTICLE TAGS TO ENHANCE TISSUE RECOGNITION

• US 20090171330A1
• Filed: 12/28/2007
• Published: 07/02/2009
• Est. Priority Date: 12/28/2007
• Status: Abandoned Application

• Current Assignee: Spectranetics Corporation (Koninklijke Philips N.V.)
• Original Assignee: Spectranetics Corporation (Koninklijke Philips N.V.)
• Inventors: Taylor, Kevin, Splinter, Robert
• Application Number:
  US11/966,214
• Publication Number:
  US 20090171330A1
• Time in Patent Office: Days
• US Class Current: 606/13
• CPC Class Codes: A61B 18/24 with a catheter A61B18/26, A61B18/28 take precedence
• CPC Class Codes: A61B 2017/00061 spectrum
• CPC Class Codes: A61B 2018/2211 Plurality of fibres
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence

Abstract

A method of locating and ablating a target tissue is described. The method includes providing a catheter that has at least one light guide, where the light guide is adaptable to receive light from a light source. A distal portion of the catheter is advanced through vasculature of a patient towards the target tissue. A nanoparticle dye is introduced into the patient, where the nanoparticles selectively bind to the target tissue. The target tissue is mapped by detecting fluorescence light emitted from the nanoparticle dye bound to the tissue. The distal tip of the catheter is positioned adjacent to the mapped target tissue, and a light pulse is transmitted through the light guide to ablate at least a portion of the target tissue.

Claims

1. A method of locating and ablating a target tissue, the method comprising:

providing a catheter comprising at least one light guide, wherein the light guide is adaptable to receive light from a light source;

advancing a distal portion of the catheter through vasculature of a patient towards the target tissue;

introducing a nanoparticle dye into the patient, wherein the nanoparticle dye selectively binds to the target tissue;

mapping the target tissue by detecting fluorescence light emitted from the nanoparticle dye bound to the tissue;

positioning the distal tip of the catheter adjacent to the imaged target tissue; and

transmitting a light pulse through the light guide to ablate at least a portion of the target tissue.

2. The method of claim 1, wherein the nanoparticle dye includes nanoparticles comprising a metal oxide and a rare earth metal dopant.

3. The method of claim 2, wherein the metal oxide comprises yttrium oxide.

4. The method of claim 2, wherein the rare earth metal dopant comprises a lanthanide element.

5. The method of claim 4, wherein the lanthanide element comprises erbium.

6. The method of claim 4, wherein the light source is a XeCl Excimer laser.

7. The method of claim 6, wherein the light pulse to ablate the target tissue is a 308 nm laser light pulse.

8. The method of claim 1, wherein the light source irradiates the nanoparticle dye bound to the tissue to generate the fluorescence light emitted from the nanoparticle dye.

9. The method of claim 1, wherein light from the fluorescence of the nanoparticle dye is transmitted through the light guide to outline the composition of the target tissue.

10. The method of claim 1, wherein the method comprises further advancing the distal tip of the catheter into the mapped target tissue after the transmission of the light pulse, and transmitting an additional light pulse through the light guide to ablate an additional portion of the target tissue.

11. The method of claim 1, wherein the introduction of the nanoparticle dye into the patient comprises injecting the dye through a lumen in the catheter.

12. The method of claim 1, wherein the nanoparticles are selectively absorbed by a layer of the vasculature and migrate along a portion of the layer.

13. The method of claim 12, wherein the layer of the vasculature is a intima, media, or adventitia layer.

14. The method of claim 1, wherein the light guide comprises one or more optical fibers, liquid light guides, or hollow waveguides.

15. A method of locating and ablating a target tissue, the method comprising:

providing a catheter comprising a plurality of light guides, wherein at least a portion of the light guides are adaptable to receive light from an ablation light source and a fluorescence light source;

advancing a distal portion of the catheter through vasculature of a patient towards the target tissue;

introducing the nanoparticle dye into the patient, wherein the nanoparticle dye selectively binds to the target tissue;

irradiating the target tissue with excitation light transmitted from the fluorescence light source through the light guides and detecting the fluorescence emitted from the nanoparticle dye bound to the tissue to map the target tissue;

positioning the distal tip of the catheter adjacent to the mapped target tissue; and

transmitting ablation light from the ablation light source through the light guides to ablate at least a portion of the target tissue.

16. The method of claim 15, wherein the nanoparticle dye is introduced into the patient through the catheter.

17. The method of claim 15, wherein the excitation light from the fluorescence light source has a different wavelength than the ablation light from the ablation light source.

18. The method of claim 17, wherein the excitation light is infrared light and the ablation light is ultraviolet light.

19. The method of claim 15, wherein the light guides comprise optical fibers.

20. A catheter and dye kit having component parts capable of being assembled to ablate target tissue in a patient, the kit comprising:

a catheter comprising a plurality of light guides, wherein a proximal end of the light guides are adaptable to a light source;

a container that holds a nanoparticle dye; and

instructions for advancing a distal portion of the catheter through vasculature of the patient towards the target tissue;

introducing the nanoparticle dye into the patient, wherein the nanoparticle dye selectively binds to the target tissue;

mapping the target tissue by detecting fluorescence light emitted from the nanoparticle dye bound to the tissue;

positioning the distal tip of the catheter adjacent to the mapped target tissue; and

transmitting a light pulse through the light guides to ablate at least a portion of the target tissue.

21. The catheter and dye kit of claim 20, wherein the nanoparticle dye includes nanoparticles comprising a metal oxide and a rare earth metal dopant.

22. The catheter and dye kit of claim 21, wherein the rare earth metal comprises erbium.

23. The catheter and dye kit of claim 20, wherein the light source is a XeCl Excimer laser.

24. The catheter and dye kit of claim 20, wherein the light source irradiates the nanoparticle dye bound to the tissue to generate the fluorescence light emitted from the nanoparticle dye.

25. The catheter and dye kit of claim 20, wherein a fluorescence light source, which generates light at a different wavelength than the ablation light source, irradiates the nanoparticle dye bound to the tissue to generate the fluorescence light emitted from the nanoparticle dye.

26. The catheter and dye kit of claim 20, wherein light from the fluorescence of the nanoparticle dye is transmitted through the light guides of the catheter to map the target tissue.

27. The catheter and dye kit of claim 20, wherein the catheter comprises a lumen through which the nanoparticle dye flows to be introduced to the patient.

28. The catheter and dye kit of claim 20, wherein the light guides comprise optical fibers, liquid light guides, or hollow waveguides.